Huntsman Corporation 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated October 25, 2016, reports on Huntsman Corporation (the "Company") and its subsidiary, Huntsman Investments (Netherlands) BV ("HIBV"). The filing details the execution of a definitive agreement to divest specific assets.
Key Financial Metrics and Transaction Details
The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity for the reporting period. The primary financial disclosure relates to a specific divestiture transaction:
- Transaction Value: Enterprise value of $225 million.
- Assets Involved: European surfactants manufacturing facilities located in Saint-Mihiel, France; Castiglione delle Stiviere, Italy; and Barcelona, Spain.
- Buyer: Innospec International LTD (a subsidiary of Innospec Inc.).
- Working Capital: The purchase price is subject to additional working capital and other adjustments. HIBV will retain accounts receivable and certain trade payables.
Material Changes and Agreements
On October 25, 2016, HIBV exercised a previously announced put option and entered into a Share and Asset Purchase Agreement with Innospec. Concurrently, the parties executed a Deed of Amendment to the agreement. Key changes and terms include:
- Extended Deadline: The date by which closing conditions must be satisfied or waived was extended to January 31, 2017.
- Post-Closing Arrangements: Innospec or an affiliate will enter into supply and long-term tolling arrangements with a HIBV subsidiary to continue supplying certain surfactants globally.
- Closing Timeline: The transaction is expected to close by the end of the fourth quarter of 2016, subject to conditions.
Outlook, Risks, and Contingencies
The transaction is subject to customary closing conditions, including:
- Completion of representative bodies consultation processes required by French legislation.
- Clearance by applicable competition law authorities.
- Absence of a material adverse effect on the business.
If conditions are not satisfied or waived by January 31, 2017, the Purchase Agreement may be terminated under certain circumstances. The filing includes standard disclaimers that representations and warranties are for contractual risk allocation and may not reflect facts applicable to investors.
Investor Verification Checklist
- Verify the final closing date and whether the transaction closes before the end of Q4 2016.
- Monitor the status of French legislative consultation and competition law clearances.
- Confirm the final purchase price after working capital adjustments are calculated.
- Review the terms of the long-term tolling and supply agreements to assess ongoing revenue impact.
- Check for any subsequent filings regarding the termination of the agreement if the January 31, 2017 deadline is not met.